Uğur Şahin and Özlem Türeci Announce New Company 'Arife' Focused on mRNA Drugs

Uğur Şahin and Özlem Türeci, founders of BioNTech, revealed their new company 'Arife', set to focus on the research and development of mRNA-based drugs. The Mainz-based firm is expected to launch by the end of 2026.